PubMed RSS Feed - -Characterization of meibomian gland dysfunction in patients with rosacea

[rss]

Arq Bras Oftalmol. 2022 Mar 21:S0004-27492022005005209. doi: 10.5935/0004-2749.20230043. Online ahead of print.

ABSTRACT

PURPOSE: To compare ocular surface parameters in rosacea patients with those of controls.

METHODS: Ninety-three participants took part in this cross-sectional, observational, non-interventional study. These consisted of a rosacea group (n=40) and a control group (n=53). We compared objective parameters of the ocular surface, including conjunctival hyperemia, tear film stability and volume, meibomian gland dysfunction, dry eye disease, and ocular surface staining, between the two groups.

RESULTS: In the rosacea group, 69.23% were female. The mean age was 47.34 ± 12.62 years old. No statistically significant differences between groups were found in visual acuity (p=0.987), tear film parameters (tear meniscus height (p=0.338), noninvasive tear film rupture time (p=0.228), invasive rupture time (p=0.471), Schirmer's test scores (p=0.244), conjunctival hyperemia (p=0.106), and fluorescein staining (p=0.489). Significant differences were found in meibography evaluations (p=0.026), mucous layer integrity (p=0.015), and ocular surface symptoms (p<0.0001). Rosacea patients also showed important eyelid differences in glandular expressibility (p<0.001), glandular secretion pattern (p<0.001), and telangiectasia (p<0.001) compared to controls.

CONCLUSION: Meibomian gland dysfunction is frequently associated with dermatological conditions. It can be observed in morphological findings from meibography as well as lipid secretion impairment, leading to evaporative dry eye, ocular surface dysfunction, and inflammation.

PMID:35319654 | DOI:10.5935/0004-2749.20230043

{url} = URL to article

MGD has been added to the list of systemic comorbidities in rosacea.